Search This Blog

Thursday, July 23, 2020

West Pharmaceutical EPS beats by $0.34, beats on revenue

West Pharmaceutical (NYSE:WST): Q2 Non-GAAP EPS of $1.25 beats by $0.34; GAAP EPS of $1.21 beats by $0.31.
Revenue of $527.2M (+12.2% Y/Y) beats by $31.11M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)